Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2007

01.11.2007 | ORIGINAL Paper

Further Validation of the IBS-QOL: Female Mexican IBS Patients Have Poorer Quality of Life Than Females from North Carolina

verfasst von: Max Schmulson, Orianna Ortiz, Juan Manuel Mejia-Arangure, Yuming B. Hu, Carolyn Morris, Denise Arcila, Gabriela Gutierrez-Reyes, Shrikant Bangdiwala, Douglas A. Drossman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

The Irritable Bowel Syndrome (IBS)-Quality of Life (QOL) is the most extensively validated health-related quality of life (HRQOL)-specific instrument for IBS with appropriate evidence for psychometric validity. Our aim was to linguistically validate the IBS-QOL for Mexico according to standard guidelines, to conduct further psychometric validation, and to compare the HRQOL between IBS patients from Mexico and North Carolina (University of North Carolina). Construct validity was tested by correlating scores from the Mexican Spanish IBS-QOL with those for anxiety and depression obtained by the Hospital Anxiety and Depression scale. Also, HRQOL from Rome I female IBS patients who consulted a tertiary referral center in Mexico was compared with that of female patients from UNC matched by age and bowel habit. A general univariate linear model was done to determine the most important variable over HRQOL, place of origin, or bowel habit. The majority of the IBS-QOL items had a negative correlation with depression as well as with anxiety. Compared to patients from UNC, the Mexican ones reported significant lower scores on Body Image and Health Worry and a trend in Interference with activities and in the Overall score. There were some differences in Dysphoria and Interference that were related to bowel habit, independently of the place of origin. In conclusion, the IBS-QOL validated in Mexican Spanish has shown construct validity. Using this instrument we found that female IBS patients who consulted a tertiary referral center in Mexico have lower HRQOL than those in North Carolina at least in factors such as Body Image and Health Worry.
Literatur
1.
Zurück zum Zitat Testa MA, Simonson DC (1996) Assessment of quality of life outcomes. N Engl J Med 334:835–840PubMedCrossRef Testa MA, Simonson DC (1996) Assessment of quality of life outcomes. N Engl J Med 334:835–840PubMedCrossRef
2.
Zurück zum Zitat Eisen GM, Locke GR III, Provenzale D (1999) Health-related quality of life: a primer for the gastroenterologists. Am J Gastroenterol 94:2017–2021PubMedCrossRef Eisen GM, Locke GR III, Provenzale D (1999) Health-related quality of life: a primer for the gastroenterologists. Am J Gastroenterol 94:2017–2021PubMedCrossRef
3.
Zurück zum Zitat Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119:654–660PubMedCrossRef Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119:654–660PubMedCrossRef
4.
Zurück zum Zitat Schmulson M, Robles G, Kershenobich D, López RR, Hinojosa CA, Duarte CA, Bandera J (2000) Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis crónica. Rev Gastroenterol Méx 65 (Suppl 1):50 Schmulson M, Robles G, Kershenobich D, López RR, Hinojosa CA, Duarte CA, Bandera J (2000) Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis crónica. Rev Gastroenterol Méx 65 (Suppl 1):50
5.
Zurück zum Zitat Chang L (2004) Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (Suppl 7):31–39PubMedCrossRef Chang L (2004) Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (Suppl 7):31–39PubMedCrossRef
6.
Zurück zum Zitat Patrick DL, Drossman D, Frederick IO, Dicesare J, Puder KL (1998) Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 43:400–411PubMedCrossRef Patrick DL, Drossman D, Frederick IO, Dicesare J, Puder KL (1998) Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 43:400–411PubMedCrossRef
7.
Zurück zum Zitat Drossman DA, Patrick DL, Whitehead WE, Toner BD, Diamant NE, Hu Y, Jia H, Bangdiwala SI (2000) Am J Gastroenterol 95:999–1007 Drossman DA, Patrick DL, Whitehead WE, Toner BD, Diamant NE, Hu Y, Jia H, Bangdiwala SI (2000) Am J Gastroenterol 95:999–1007
8.
Zurück zum Zitat Acquadro C, Conway K, Giroudet C, Mear I (2004) Linguistic validation manual for patient-reported outcomes (PRO) instruments. MAPI Research Institute, Lyons, France Acquadro C, Conway K, Giroudet C, Mear I (2004) Linguistic validation manual for patient-reported outcomes (PRO) instruments. MAPI Research Institute, Lyons, France
9.
Zurück zum Zitat Bijkerk CJ, de Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW (2003) Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics. Am J Gastroenterol 98:122–127PubMedCrossRef Bijkerk CJ, de Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW (2003) Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics. Am J Gastroenterol 98:122–127PubMedCrossRef
10.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef
11.
Zurück zum Zitat López-Alvarenga JC, Vzquez-Velzquez V, Arcila-Martínez D, Sierra-Ovando AE, Gonzles-Barranco J, Salín-Pascual RJ (2002) Exactitud y utilidad diagnóstica del Hospital Anxiety and Depresión Scale (HAD) en una muestra de sujetos obesos mexicanos. Rev Invest Clin 54:403–409PubMed López-Alvarenga JC, Vzquez-Velzquez V, Arcila-Martínez D, Sierra-Ovando AE, Gonzles-Barranco J, Salín-Pascual RJ (2002) Exactitud y utilidad diagnóstica del Hospital Anxiety and Depresión Scale (HAD) en una muestra de sujetos obesos mexicanos. Rev Invest Clin 54:403–409PubMed
12.
Zurück zum Zitat Thompson WG, Working Team for Functional Bowel Disorders (1994) Functional bowel disorders and functional abdominal pain. In: The functional gastrointestinal disorders. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Little, Brown, Boston, pp 115–173 Thompson WG, Working Team for Functional Bowel Disorders (1994) Functional bowel disorders and functional abdominal pain. In: The functional gastrointestinal disorders. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Little, Brown, Boston, pp 115–173
13.
Zurück zum Zitat Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternative. Gastroenterology 128:580–589PubMedCrossRef Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternative. Gastroenterology 128:580–589PubMedCrossRef
14.
Zurück zum Zitat American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002) Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97(Suppl):S1–S5 American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002) Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97(Suppl):S1–S5
15.
Zurück zum Zitat Bergman JF, Chassany O (1998) The role of quality of life in functional gastrointestinal disorders: regulatory issues. Eur J Surg 83(Suppl 5):87–91 Bergman JF, Chassany O (1998) The role of quality of life in functional gastrointestinal disorders: regulatory issues. Eur J Surg 83(Suppl 5):87–91
16.
Zurück zum Zitat Zuniga MA, Carrillo-Jimenez GT, Fos PJ, Gandek B, Medina-Moreno MR (1999) Evaluación del estado de salud con la encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118PubMed Zuniga MA, Carrillo-Jimenez GT, Fos PJ, Gandek B, Medina-Moreno MR (1999) Evaluación del estado de salud con la encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118PubMed
17.
Zurück zum Zitat Schmulson M, Ortiz O, Hinojosa C, Arcila D (2006) A single session of reassurance can acutely improve the self-perception of impairment in patients with IBS. J Psychosom Res (in press) Schmulson M, Ortiz O, Hinojosa C, Arcila D (2006) A single session of reassurance can acutely improve the self-perception of impairment in patients with IBS. J Psychosom Res (in press)
18.
Zurück zum Zitat Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67–71PubMedCrossRef Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67–71PubMedCrossRef
19.
Zurück zum Zitat Badia X, Mearin F, Balboa A (2002) Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 20:749–758PubMedCrossRef Badia X, Mearin F, Balboa A (2002) Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 20:749–758PubMedCrossRef
20.
Zurück zum Zitat Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (2004) Impact of functional gastrointestinal disorders on health related quality of life: a population-based case-control study. Aliment Pharmacol Ther 19:233–242PubMedCrossRef Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (2004) Impact of functional gastrointestinal disorders on health related quality of life: a population-based case-control study. Aliment Pharmacol Ther 19:233–242PubMedCrossRef
21.
Zurück zum Zitat Frank L., Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C (2002) Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24:675–689PubMedCrossRef Frank L., Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C (2002) Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24:675–689PubMedCrossRef
22.
Zurück zum Zitat Kellow J, Lee OY, Chang FY, Thongsawat S, Mazlam MZ, Yuen H, Gwee KA, Bak YT, Jones J, Wagner A (2003) An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52:671–676PubMedCrossRef Kellow J, Lee OY, Chang FY, Thongsawat S, Mazlam MZ, Yuen H, Gwee KA, Bak YT, Jones J, Wagner A (2003) An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52:671–676PubMedCrossRef
23.
Zurück zum Zitat Schmulson M, Remes JM, Olivas T, Valdovinos MA, Hinojosa C, Chang L, Mayer E, Naliboff B (2003) Clinical characteristics and QOL in IBS patients from Mexico and the USA: Are they different? Gastroenterology 124 (Suppl 1):A-395 Schmulson M, Remes JM, Olivas T, Valdovinos MA, Hinojosa C, Chang L, Mayer E, Naliboff B (2003) Clinical characteristics and QOL in IBS patients from Mexico and the USA: Are they different? Gastroenterology 124 (Suppl 1):A-395
24.
Zurück zum Zitat Carr AJ, Gibson B, Robinson PG (2001) Measuring quality of life. Is quality of life determined by expectations or experience? BMJ 322:1240–1243PubMedCrossRef Carr AJ, Gibson B, Robinson PG (2001) Measuring quality of life. Is quality of life determined by expectations or experience? BMJ 322:1240–1243PubMedCrossRef
25.
Zurück zum Zitat Park MI, Camilleri M (2005) Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am 34:305–317PubMedCrossRef Park MI, Camilleri M (2005) Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am 34:305–317PubMedCrossRef
26.
Zurück zum Zitat Hahn BA, Ya S, Strassels S (1999) Impact of irritable bowel syndrome in the United States and United Kingdom. Digestion 60:77–81 Hahn BA, Ya S, Strassels S (1999) Impact of irritable bowel syndrome in the United States and United Kingdom. Digestion 60:77–81
Metadaten
Titel
Further Validation of the IBS-QOL: Female Mexican IBS Patients Have Poorer Quality of Life Than Females from North Carolina
verfasst von
Max Schmulson
Orianna Ortiz
Juan Manuel Mejia-Arangure
Yuming B. Hu
Carolyn Morris
Denise Arcila
Gabriela Gutierrez-Reyes
Shrikant Bangdiwala
Douglas A. Drossman
Publikationsdatum
01.11.2007
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2007
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9689-9

Weitere Artikel der Ausgabe 11/2007

Digestive Diseases and Sciences 11/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.